对 "在非临床试验环境中复发的好发组织学 Wilms 肿瘤的疗效 "的更正。

IF 2.4 3区医学 Q2 HEMATOLOGY

Pediatric Blood & Cancer Pub Date : 2025-02-14 DOI:10.1002/pbc.31601

{"title":"对 \"在非临床试验环境中复发的好发组织学 Wilms 肿瘤的疗效 \"的更正。","authors":"","doi":"10.1002/pbc.31601","DOIUrl":null,"url":null,"abstract":"Schneller N, Daw N, Throckmorton W, Mullen E, DeSmith K, Mascarenhas L, O'Connell C, Fernandez CV, Sutton KS, Venkatramani R.\n “Outcomes of Relapsed Favorable-Histology Wilms Tumor in Non-Clinical Trial Setting,” Pediatr Blood Cancer 72, no 1 (2025): e31347. https://doi.org/10.1002/pbc.31347. Epub 2024 Oct 12. PMID: 39394977.One of the author's names is spelled wrong. “Marcarenhas L” should be spelled “Mascarenhas L”.We apologize for this error.","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":"72 5","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pbc.31601","citationCount":"0","resultStr":"{\"title\":\"Correction to “Outcomes of Relapsed Favorable-Histology Wilms Tumor in Non-Clinical Trial Setting”\",\"authors\":\"\",\"doi\":\"10.1002/pbc.31601\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Schneller N, Daw N, Throckmorton W, Mullen E, DeSmith K, Mascarenhas L, O'Connell C, Fernandez CV, Sutton KS, Venkatramani R.\\n “Outcomes of Relapsed Favorable-Histology Wilms Tumor in Non-Clinical Trial Setting,” Pediatr Blood Cancer 72, no 1 (2025): e31347. https://doi.org/10.1002/pbc.31347. Epub 2024 Oct 12. PMID: 39394977.One of the author's names is spelled wrong. “Marcarenhas L” should be spelled “Mascarenhas L”.We apologize for this error.\",\"PeriodicalId\":19822,\"journal\":{\"name\":\"Pediatric Blood & Cancer\",\"volume\":\"72 5\",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-02-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pbc.31601\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Blood & Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pbc.31601\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Blood & Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pbc.31601","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction to “Outcomes of Relapsed Favorable-Histology Wilms Tumor in Non-Clinical Trial Setting”

Schneller N, Daw N, Throckmorton W, Mullen E, DeSmith K, Mascarenhas L, O'Connell C, Fernandez CV, Sutton KS, Venkatramani R. “Outcomes of Relapsed Favorable-Histology Wilms Tumor in Non-Clinical Trial Setting,” Pediatr Blood Cancer 72, no 1 (2025): e31347. https://doi.org/10.1002/pbc.31347. Epub 2024 Oct 12. PMID: 39394977.

One of the author's names is spelled wrong. “Marcarenhas L” should be spelled “Mascarenhas L”.

We apologize for this error.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Pediatric Blood & Cancer 医学-小儿科

CiteScore

4.90

自引率

9.40%

发文量

546

审稿时长

1.5 months

期刊介绍： Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.